Clinical impact of ultrasonography between the 10th and the 13th week of pregnancy.
DOI:
https://doi.org/10.20344/amp.1975Abstract
The authors aimed to assess the impact of a routine ultrasound examination performed between 10 and 13 weeks of pregnancy. During a thirty month period, 778 ultrasound examinations between 10 and 13 weeks of pregnancy were performed, in women referred to our hospital. Transvaginal ultrasound was systematically adopted and the parameters obtained were introduced in a computerized data base. Biographic data, first day of menses (whenever possible), menstrual cycle characteristics, eventual use of hormonal contraception in the three months before last menses, antecedents of chromosomal abnormalities, number of foetuses and chorionicity, foetal vitality, crown-rump length, nuchal translucency and foetal heart rate were registered in all examinations. The median gestational age at the time of examination was 12.5 weeks (9-14.3). The median of maternal age was 29 years (14-44), maternal age prevalence higher or equal to 35 years was 17%. Fifty two per cent of women had usually regular menstrual cycles and 11% ignored last menses. In 74% of cases discrepancy between amenorrhea and ultrasound derived gestational age was inferior to one week and in 19% superior. The median of nuchal translucency was 1.4 mm (0.5-10), 7% of all cases had a nuchal translucency higher or equal to 2.5 mm. If maternal age criteria had been decisive for diagnostic invasive procedures, they would have been made in 135 cases. Considering nuchal translucency value combined with maternal age, it should have been done in 63 cases. In our series, invasive testing was performed in 31 (5%) cases. Eight women with fetuses with abnormal karyotypes decided for termination of pregnancy. The importance of ultrasound examination between 10 and 13 weeks seems unquestionable, allowing the correction of gestational age, multiple pregnancy characterisation and chromosomal abnormalities screening.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.